The behavioral pharmacology of hallucinogens

2007/07/21 by William E. Fantegrossi, Kevin S. Murnane, Chad J. Reissig · 3 citations
Chemistry · Neuroscience · Psychology · #Chemical synthesis and alkaloids #Neurotransmitter Receptor Influence on Behavior #Psychedelics and Drug Studies

paper · doi:10.1016/j.bcp.2007.07.018

openalex publication_date 2007/07/21 · crossref created 2007/07/21 · crossref issued 2008/01/01 · crossref published 2008/01/01 · crossref published-print 2008/01/01 · crossref deposited 2019/05/01 · openalex created_date 2025/10/10 · crossref indexed 2026/07/24 · openalex updated_date 2026/07/25

Citations

• Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
• Dose-Response Study of N,N-Dimethyltryptamine in Humans
• Dose-Response Study of N,N-Dimethyltryptamine in Humans
• Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
• Functional Selectivity and Classical Concepts of Quantitative Pharmacology
• Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters Are Agonists of a Rat Trace Amine Receptor

Cited by

• Characterization of the synthesis of N,N‐dimethyltryptamine by reductive amination using gas chromatography ion trap mass spectrometry
• Psychedelics and schizophrenia
• Dimethyltryptamine [wikipedia]